| [1] |
Ragusa F， Fallahi P， Elia G，et al.Hashimotos′ thyroiditis：epidemiology，pathogenesis，clinic and therapy[J]. Best Pract Res Clin Endocrinol Metab， 2019， 33(6)：101367.DOI： 10.1016/j.beem.2019.101367.
|
| [2] |
|
| [3] |
|
| [4] |
Ralli M, Angeletti D, Fiore M, et al. Hashimoto′s thyroiditis：an update on pathogenicmechanisms，diagnostic protocols，therapeutic strategies，and potential malignant transformation[J]. Autoimmun Rev， 2020， 19(10)：102649.DOI： 10.1016/j.autrev.2020.102649.
|
| [5] |
Avery JC， Hoffmann PR.Selenium，selenoproteins，and immunity[J]. Nutrients， 2018， 10(9)：1203.DOI： 10.3390/nu10091203.
|
| [6] |
Weetman AP. An update on the pathogenesis of Hashimoto′s thyroiditis[J]. J Endocrinol Invest， 2021， 44(5)：883-890.DOI： 10.1007/s40618-020-01477-1.
|
| [7] |
Wu Q， Rayman MP， Lv H，et al.Low population selenium status is associated with increased prevalence of thyroid disease[J]. J Clin Endocrinol Metab， 2015， 100(11)：4037-4047.DOI： 10.1210/jc.2015-2222.
|
| [8] |
Hu S， Rayman MP.Multiple nutritional factors and the risk of Hashimoto's thyroiditis[J]. Thyroid， 2017， 27(5)：597-610.DOI： 10.1089/thy.2016.0635.
|
| [9] |
Rostami R， Nourooz-Zadeh S， Mohammadi A，et al.Serum selenium status and its interrelationship with serum biomarkers of thyroid function and antioxidant defense in Hashimoto's thyroiditis[J]. Antioxidants (Basel)， 2020， 9(11)：1070.DOI： 10.3390/antiox9111070.
|
| [10] |
Ventura M， Melo M， Carrilho F．Selenium and thyroid disease：from pathophysiology to treatment[J]. Int J Endocrinol， 2017(2017)：1297658.DOI： 10.1155/2017/1297658.
|
| [11] |
Qian F， Misra S， Prabhu KS.Selenium and selenoproteins in prostanoid metabolism and immunity[J]. Crit Rev Biochem Mol Biol， 2019， 54(6)：484-516.DOI： 10.1080/10409238.2020.1717430.
|
| [12] |
Ghasemi F， Khoshmirsafa M， Safari E，et al.Vitamin E and selenium improve mesenchymal stem cell conditioned media immunomodulatory effects[J]. Stem Cell Investig， 2021(8)：9.DOI： 10.21037/sci-2020-008.
|
| [13] |
Rayman MP. Selenium intake, status, and health: a complex relationship[J]. Hormones (Athens)， 2020， 19(1)：9-14.DOI： 10.1007/s42000-019-00125-5.
|
| [14] |
|
| [15] |
Ihnatowicz P， Drywien＇ M, Wtor P，et al.The importance of nutritional factors and dietary management of Hashimoto′s thyroiditis[J]. Ann Agric Environ Med， 2020， 27(2)：184-193.DOI： 10.26444/aaem/112331.
|
| [16] |
Charoenngam N， Holick MF.Immunologic effects of vitamin D on human health and disease[J]. Nutrients， 2020， 12(7)：2097.DOI： 10.3390/nu12072097.
|
| [17] |
|
| [18] |
Krysiak R， Kowalcze K， Okopień B．Selenomethionine potentiates the impact of vitamin D on thyroid autoimmunity in euthyroid women with Hashimoto's thyroiditis and low vitamin D status[J]. Pharmacol Rep， 2019， 71(2)：367-373.DOI： 10.1016/j.pharep.2018.12.006.
|
| [19] |
侯丽萍，耿建林，谷巍，等．硒酵母联合维生素D对实验性自身免疫甲状腺炎大鼠甲状腺相关激素及抗体的影响[J]. 天津医药， 2021， 49(2)：136-141.DOI： 10.11958/20201366. |
| [20] |
Krysiak R， Okopien B．The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto′s thyroiditis[J]. J Clin Endocrinol Metab， 2011， 96(7)：2206-2215.DOI： 10.1210/jc.2010-2986.
|
| [21] |
Yu L, Zhou L, Xu E, et al. Levothyroxine monotherapy versus levothyroxine and selenium combination therapy in chronic lymphocytic thyroiditis[J]. J Endocrinol Invest， 2017， 40(11)：1243-1250.DOI： 10.1007/s40618-017-0693-z.
|
| [22] |
Wichman J， Winther KH， Bonnema SJ，et al.Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis：a systematic review and meta-analysis[J]. Thyroid， 2016， 26(12)：1681-1692.DOI： 10.1089/thy.2016.0256.
|
| [23] |
孙海君．硒酵母联合左旋甲状腺素片治疗桥本甲状腺炎的临床效果观察[J].中外女性健康研究，2020(9)：46-47.
|
| [24] |
|
| [25] |
Krysiak R， Szkróbka W， Okopień B．The effect of hypolipidemic agents on thyroid autoimmunity in women with Hashimoto′s thyroiditis treated with levothyroxine and selenomethionine[J]. Exp Clin Endocrinol Diabetes， 2018， 126(5)：321-326.DOI： 10.1055/s-0043-120342.
|
| [26] |
Ferrari SM， Elia G， Ragusa F，et al.The protective effect of myo-inositol on human thyrocytes[J]. Rev Endocr Metab Disord， 2018， 19(4)：355-362.DOI： 10.1007/s11154-018-9476-x.
|
| [27] |
Nordio M，Basciani S．Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto′s patients with subclinical hypothyroidism[J].Eur Rev Med Pharmacol Sci，2017，21(2 Suppl)：51-59.
|